A physician-managed partnership that lets your practice offer prescription peptide protocols — with zero medical liability, zero inventory, and recurring monthly commissions starting from your first referral.
Weight management, tissue recovery, longevity, sexual health — your clients are already researching peptides. Without a medical director, pharmacy contracts, and a compliance infrastructure, offering these in-house isn't practical for most practices.
Adding peptide therapy in-house requires capital, time, and clinical infrastructure most practices don't have. The partnership model removes every barrier — without compromising clinical integrity.
| Building In-House | This Partnership | |
|---|---|---|
| Medical Director | $150,000+/year | Provided — physician-managed |
| Pharmacy Contracts | 6–12 month process | Provided — licensed 503A pharmacy |
| Compliance & Regulatory | Significant ongoing overhead | Fully handled by platform |
| Inventory Risk | High — you hold stock | Zero — ships direct to patient |
| Time to Launch | 6–12 months minimum | Under 7 days |
| Upfront Investment | Substantial | $79 one-time + $8/month |
| First Revenue | Months after setup | From your first referral — 20% immediately |
Your role is the introduction. Everything clinical, logistical, and administrative is managed by the platform.
Every protocol requires physician approval. All compounds dispensed by a licensed domestic 503A pharmacy — pharmaceutical-grade standards, shipped direct to patient.
Additional protocols available: Glutathione, Methylene Blue, Semax, Selank, DSIP, MOTS-c, Thymosin Alpha-1, Melanotan II, Dihexa, and more. Full menu provided at onboarding.
A no-pressure 20-minute call to walk through the partnership model, what your practice would earn, and whether it's the right fit. No commitment required.
Prefer email? [email protected]